Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
CLEVELAND--(BUSINESS WIRE)--Jan 17, 2024--
Stay updated with breaking news from Solvent Interaction Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CLEVELAND--(BUSINESS WIRE)--Jan 17, 2024--
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
CLEVELAND--(BUSINESS WIRE)--Jun 28, 2023--
NCCN® Guidelines now include IsoPSA to further define the probability of high-grade prostate cancerCLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that its prostate cancer t...
Posted on 196 Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that it has closed a Series D round of $17.4 million. The round was led by LYFE Capital, with participation from existing investors including Cleveland Clinic and others. Following the close of the round, the company received a term sheet for a $2M convertible note, expected to close shortly. Funds raised will be used to expand commercialization of IsoPSAâ€...